We are live on ! Find out more
LVACW

LAVA Medtech Acquisition Corp. Warrants
LVACW

Delisted

LVACW was delisted on the 12th of May, 2023.

31 hedge funds and large institutions have $1.15M invested in LAVA Medtech Acquisition Corp. Warrants in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

3% less funds holding

Funds holding: 3231 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

61% less capital invested

Capital invested by funds: $2.92M → $1.15M (-$1.77M)

Holders
31
Holders Change
-1
Holders Change %
-3.13%
% of All Funds
0.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
2
Closed
4
Calls
$6K
Puts
Net Calls
+$6K
Net Calls Change
-$3K

LVACW Hedge Fund Activity: Q3 2022 in Review

31 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Warrants (LVACW) for Q3 2022, worth a combined $1.15M — down 61% from $2.92M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of LVACW and 3 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 4 added.

The largest buyer was Periscope Capital, adding an estimated $40.2K. The largest seller was Mangrove Partners, exiting entirely with an estimated $1.99M sold.

  • 31 institutional investors held LAVA Medtech Acquisition Corp. Warrants (LVACW) as of Q3 2022, down from 32 in Q2 2022.
  • Funds reported $1.15M of LAVA Medtech Acquisition Corp. Warrants stock for Q3 2022, down 61% quarter-over-quarter.
  • 3 funds opened new LAVA Medtech Acquisition Corp. Warrants positions in Q3 2022 and 4 closed out, a net change of -1 holder.
  • The largest LAVA Medtech Acquisition Corp. Warrants buyer in Q3 2022 was Periscope Capital, an estimated $40.2K added.
  • The largest LAVA Medtech Acquisition Corp. Warrants seller in Q3 2022 was Mangrove Partners, an estimated $1.99M sold.

Based on aggregated 13F filings for Q3 2022.